+ Watch QCOR
on My Watchlist
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
Morningstar.com classifies this as a "Financially Healthy Aggressive Growth" stock, and zacks.com gives it a PEG ratio lower than most stocks so classified. I'm interpreting those 2 things as meaning QCOR deserves valuations I would normally be uncomfortable with.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions